New allergy pill aims to clear stuffy noses in asthma patients
NCT ID NCT07168473
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This phase 3 trial tests whether a new drug called DW1807 works better than another drug (DW1807-R2) for people with year-round allergic rhinitis who also have asthma. About 274 adults will take one of the two drugs daily for 4 weeks. The main goal is to see if DW1807 improves nasal symptoms like stuffiness and sneezing more than the comparator.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
DW1807 (experimental drug) and DW1807-R2 (active comparator drug)
What this could lead to
If DW1807 works better, it could offer a new treatment option for people with both year-round allergies and asthma, easing nasal symptoms.
What could go wrong
This is a short 4-week study with 274 participants, so results may not apply long-term or to everyone. The drug may not prove superior to the comparator.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Konkuk University Medical Center
RECRUITINGSeoul, South Korea